Skip to main content
BIOA logo

BIOA · BioAge Labs, Inc. · Webcasts, Transcripts & Audio

Track BIOA — free
$5.22 -0.33 (-5.95%) At close · Nov 16 Play latest call Q1 2026 earnings call transcript
Market Cap
$239.90M
Shares
45.96M
Volume · Nov 16 689.11K Avg daily vol (3M) 733.08K

BioAge Labs, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for BioAge Labs, Inc. (BIOA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-11-19
BioAge Labs, Inc. (BIOA) November 19, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-16
BioAge Labs, Inc. (BIOA) November 16, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-12
BioAge Labs, Inc. (BIOA) November 12, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-10
BioAge Labs, Inc. (BIOA) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-09-30
BioAge Labs, Inc. (BIOA) Q2 2026 Earnings Call
Revenue
$2.45M
▲ 1.6% YoY
Diluted EPS
$-0.58
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-16
BioAge Labs, Inc. (BIOA) September 16, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-09
BioAge Labs, Inc. (BIOA) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-08
BioAge Labs, Inc. (BIOA) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-04
BioAge Labs, Inc. (BIOA) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-21
BioAge Labs, Inc. (BIOA) Q1 2026 Earnings Call Transcript
Confident tone Cardiovascular Risk Program Ophthalmology / DME Indication BGE-102 Phase 1 Results
Revenue
$2.77M
▲ 91% YoY
Diluted EPS
$-0.52
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–10 of 10 webcasts
Key facts CIK 1709941 CUSIP 09077V100 13F (30d) 129 filings 125 filers Visit website Investor relations